Orthofix Medical Inc. (NASDAQ: OFIX) stands out in the healthcare sector, particularly within the medical devices industry, where it has carved out a niche through its innovative solutions for spinal..
Tilray Brands, Inc. (NASDAQ: TLRY) stands out in the healthcare sector as a dynamic player in the specialty and generic drug manufacturing niche. Based in Leamington, Canada, Tilray has crafted..
Relay Therapeutics, Inc. (NASDAQ: RLAY) is a clinical-stage biotechnology company based in Cambridge, Massachusetts. Specializing in precision medicines, Relay is transforming drug discovery with a focus on oncology and genetic..
Myriad Genetics, Inc. (NASDAQ: MYGN) operates at the forefront of the healthcare sector as a leading player in diagnostics and research. With a market capitalization of $683.26 million, this Salt..
Altimmune, Inc. (ALT), a prominent player in the biotechnology sector, is capturing the spotlight with a potential upside of 236.63% based on the latest analyst ratings. This clinical-stage biopharmaceutical company..
Investors seeking promising opportunities in the healthcare sector might find Theravance Biopharma, Inc. (NASDAQ: TBPH) an attractive prospect. As a biopharmaceutical company focused on developing and commercializing innovative therapies, Theravance..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a prominent player in the medical devices industry, has captured investor attention with its innovative approach to orthopedic solutions, particularly in bunion correction. Despite..
Autolus Therapeutics plc (NASDAQ: AUTL) is a clinical-stage biopharmaceutical company that has been turning heads on Wall Street due to its promising advancements in T cell therapies aimed at treating..
Avanos Medical, Inc. (AVNS) stands at the intersection of innovation and healthcare, providing essential medical device solutions across a global market. With a market capitalization of $516.64 million, Avanos operates..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is drawing considerable attention from investors with its robust pipeline aimed at overcoming cancer resistance mechanisms. With a market cap of..
Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) a compelling prospect. This Germantown, Maryland-based biopharmaceutical company, known for its pioneering work in gene and..
RxSight, Inc. (RXST), a pioneering player in the healthcare sector, commands attention with its innovative approach to medical devices, particularly in the realm of cataract surgery. Headquartered in Aliso Viejo,..
SIGA Technologies Inc. (NASDAQ: SIGA) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $454.02 million, SIGA is a..
For investors with a keen interest in biotechnology, Arbutus Biopharma Corporation (NASDAQ: ABUS) presents an intriguing opportunity. Operating in the healthcare sector, Arbutus is a clinical-stage biopharmaceutical company focused on..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a promising player in the biotechnology sector, is capturing the attention of investors with its potential for significant upside. The company’s stock is currently priced..
Verastem, Inc. (NASDAQ: VSTM) has carved out a niche within the competitive and high-stakes biotechnology sector. Based in Needham, Massachusetts, the company is making strides in the development and commercialization..
MBX Biosciences, Inc. (NASDAQ: MBX), a burgeoning name in the biotechnology sector, is capturing investor attention with its innovative approach to addressing endocrine and metabolic disorders. Based in Carmel, Indiana,..
iRadimed Corporation (NASDAQ: IRMD) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative MRI-compatible solutions. Headquartered in Winter Springs, Florida, iRadimed is a..
Abivax SA (ABVX), a French biotechnology company headquartered in Paris, is capturing investor attention with its promising clinical-stage therapeutics designed to stabilize immune responses in patients with chronic inflammatory diseases...
Enliven Therapeutics, Inc. (NASDAQ: ELVN) is attracting attention in the biotechnology sector with a notable 93.34% potential upside, according to analyst ratings. This Boulder, Colorado-based clinical-stage biopharmaceutical company specializes in..
